Sol-Gel Technologies Ltd.
SLGL · XNASCIK 1684693fmd_1HHPJRNFYQ2CZS3RS3973EMHHHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 19 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 23 | 9 | 31 | 4 | 2 | 12 | 19 |
| Research and development | 17 | 26 | 28 | 41 | 28 | 20 | 13 | 24 | 18 | 23 |
| Operating income | (21) | (32) | (34) | (26) | (30) | 3 | (16) | (29) | (12) | (8) |
| Income before taxes | – | (32) | (32) | (25) | (29) | 3 | – | – | – | – |
| Income tax expense | – | – | – | 0 | 0 | 0 | – | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | (25) | (29) | 3 | – | – | – | – |
| Net income | (21) | (32) | (32) | (25) | (29) | 3 | (15) | (27) | (11) | (6) |